Biocartis announces H1 2017 results
Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART…
Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART…
SCOR announces the launch of a new 3-year contingent capital facility. This takes the form of a contingent equity line,…
Ingenico Group today announces an adjustment to its objective for revenue growth for H2 2016. This adjustment is due to…
. Revenue of €1.133 billion up 12% on a comparable basis up 7% on a reported basis Strong growth across most regions E…